APP and Alzheimer disease: While β- and γ-secretases cooperatively convert APP into Aβ, α-secretase is a competing pathway for APP which diverts the substrate APP into production of sAPPα, which is non toxic and effectively prevents the formation of amyloid plaques and AD-related dementia.